全文获取类型
收费全文 | 33421篇 |
免费 | 2942篇 |
国内免费 | 23篇 |
出版年
2022年 | 244篇 |
2021年 | 470篇 |
2020年 | 277篇 |
2019年 | 380篇 |
2018年 | 418篇 |
2017年 | 365篇 |
2016年 | 696篇 |
2015年 | 1195篇 |
2014年 | 1261篇 |
2013年 | 1771篇 |
2012年 | 2079篇 |
2011年 | 2144篇 |
2010年 | 1336篇 |
2009年 | 1255篇 |
2008年 | 1842篇 |
2007年 | 1903篇 |
2006年 | 1688篇 |
2005年 | 1743篇 |
2004年 | 1719篇 |
2003年 | 1633篇 |
2002年 | 1554篇 |
2001年 | 353篇 |
2000年 | 259篇 |
1999年 | 342篇 |
1998年 | 420篇 |
1997年 | 290篇 |
1996年 | 286篇 |
1995年 | 258篇 |
1994年 | 244篇 |
1993年 | 251篇 |
1992年 | 261篇 |
1991年 | 214篇 |
1990年 | 220篇 |
1989年 | 200篇 |
1988年 | 202篇 |
1987年 | 221篇 |
1986年 | 196篇 |
1985年 | 217篇 |
1984年 | 271篇 |
1983年 | 252篇 |
1982年 | 307篇 |
1981年 | 308篇 |
1980年 | 317篇 |
1979年 | 219篇 |
1978年 | 215篇 |
1977年 | 234篇 |
1976年 | 215篇 |
1975年 | 183篇 |
1974年 | 199篇 |
1973年 | 187篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Based on its proven anabolic effects on bone in osteoporosis patients, recombinant parathyroid hormone (PTH1-34) has been evaluated as a potential therapy for skeletal repair. In animals, the effect of PTH1-34 has been investigated in various skeletal repair models such as fractures, allografting, spinal arthrodesis and distraction
osteogenesis. These studies have demonstrated that intermittent PTH1-34 treatment enhances and accelerates the skeletal repair process via a number of mechanisms, which include effects on mesenchymal
stem cells, angiogenesis, chondrogenesis, bone formation and resorption. Furthermore, PTH1-34 has been shown to enhance bone repair in challenged animal models of aging, inflammatory arthritis and glucocorticoid-induced
bone loss. This pre-clinical success has led to off-label clinical use and a number of case reports documenting PTH1-34 treatment of delayed-unions and non-unions have been published. Although a recently completed phase 2 clinical trial of PTH1-34 treatment of patients with radius fracture has failed to achieve its primary outcome, largely because of effective healing
in the placebo group, several secondary outcomes are statistically significant, highlighting important issues concerning the
appropriate patient population for PTH1-34 therapy in skeletal repair. Here, we review our current knowledge of the effects of PTH1-34 therapy for bone healing, enumerate several critical unresolved issues (e.g., appropriate dosing regimen and indications)
and discuss the long-term potential of this drug as an adjuvant for endogenous tissue engineering. 相似文献
2.
Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells. 总被引:3,自引:0,他引:3
Natalia Nieto Scott L Friedman Arthur I Cederbaum 《The Journal of biological chemistry》2002,277(12):9853-9864
To evaluate possible fibrogenic effects of CYP2E1-dependent generation of reactive oxygen species, a model was developed using co-cultures of HepG2 cells, which do (E47 cells) or do not (C34 cells) express cytochrome P450 2E1 (CYP2E1) with stellate cells. There was an increase in intra- and extracellular H(2)O(2), lipid peroxidation, and collagen type I protein in stellate cells co-cultured with E47 cells compared with stellate cells alone or co-cultured with C34 cells. The increase in collagen was prevented by antioxidants and a CYP2E1 inhibitor. CYP3A4 did not mimic the stimulatory effects found with CYP2E1. Collagen mRNA levels remained unchanged, and pulse-chase analysis indicated similar half-lives of collagen I protein between both co-cultures. However, collagen protein synthesis was increased in E47 co-culture. Hepatocytes from pyrazole-treated rats (with high levels of CYP2E1) induced collagen protein in primary stellate cells, and antioxidants and CYP2E1 inhibitors blocked this effect. These results suggest that increased translation of collagen mRNA by CYP2E1-derived reactive oxygen species is responsible for the increase in collagen protein produced by the E47 co-culture. These co-culture models may be useful for understanding the impact of CYP2E1-derived ROS on stellate cell function and activation. 相似文献
3.
4.
5.
6.
Minh Thac Nguyen Ryan Denniston Hien Thi Thu Nguyen Tuan Anh Hoang Hana Ross Anthony D. So 《PloS one》2014,9(1)
Illicit trade carries the potential to magnify existing tobacco-related health care costs through increased availability of untaxed and inexpensive cigarettes. What is known with respect to the magnitude of illicit trade for Vietnam is produced primarily by the industry, and methodologies are typically opaque. Independent assessment of the illicit cigarette trade in Vietnam is vital to tobacco control policy. This paper measures the magnitude of illicit cigarette trade for Vietnam between 1998 and 2010 using two methods, discrepancies between legitimate domestic cigarette sales and domestic tobacco consumption estimated from surveys, and trade discrepancies as recorded by Vietnam and trade partners. The results indicate that Vietnam likely experienced net smuggling in during the period studied. With the inclusion of adjustments for survey respondent under-reporting, inward illicit trade likely occurred in three of the four years for which surveys were available. Discrepancies in trade records indicate that the value of smuggled cigarettes into Vietnam ranges from $100 million to $300 million between 2000 and 2010 and that these cigarettes primarily originate in Singapore, Hong Kong, Macao, Malaysia, and Australia. Notable differences in trends over time exist between the two methods, but by comparison, the industry estimates consistently place the magnitude of illicit trade at the upper bounds of what this study shows. The unavailability of annual, survey-based estimates of consumption may obscure the true, annual trend over time. Second, as surveys changed over time, estimates relying on them may be inconsistent with one another. Finally, these two methods measure different components of illicit trade, specifically consumption of illicit cigarettes regardless of origin and smuggling of cigarettes into a particular market. However, absent a gold standard, comparisons of different approaches to illicit trade measurement serve efforts to refine and improve measurement approaches and estimates. 相似文献
7.
Arthur B. Harris 《BMJ (Clinical research ed.)》1889,2(1508):1188-1189
8.
9.
Edward Harrison 《BMJ (Clinical research ed.)》1916,1(2888):645-647
10.